Target intelligence / Profile preview

Eukaryotic plasma membrane (PM)

Target
PM
Molecular classification
Lipid bilayer, Cellular structure, Other
01

Overview

The eukaryotic plasma membrane is a complex, semi-permeable lipid bilayer that defines the boundary of the cell and maintains the essential differences between the cytosol and the extracellular environment (Alberts et al., 2002). It is primarily composed of phospholipids, cholesterol, and integral or peripheral proteins that facilitate vital processes such as nutrient transport, waste excretion, and signal transduction (Lodish et al., 2000). While the membrane contains numerous specific protein targets like receptors and ion channels, the lipid bilayer itself serves as a target for certain therapeutic agents, particularly in the treatment of fungal and parasitic infections (van Meer et al., 2008). For instance, polyene antifungals like Amphotericin B exert their effect by binding to ergosterol within the fungal plasma membrane, leading to the formation of aqueous pores and subsequent cell death (Baginski & Czub, 2009). However, targeting the plasma membrane presents significant safety challenges, as the structural similarities between host and pathogen membranes can lead to off-target effects such as hemolysis and systemic toxicity.

Other names
Cell membranePlasmalemmaCytoplasmic membranePhospholipid bilayer
02

Mechanism of action

Pore formation, Lipid bilayer disruption, Alteration of membrane fluidity, Inhibition of phospholipid metabolism, Modulation of membrane-bound protein activity

03

Biological functions

Selective permeabilitySignal transductionCell-cell communicationIon homeostasisEndocytosisExocytosisOther
04

Disease associations

InfectionCancerNeurodegenerative diseaseOther
05

Safety considerations

Non-specific cytotoxicityHemolysisLow therapeutic indexOff-target effects on host cell membranes
06

Interacting drugs

Amphotericin B

5 more in the full profile.

07

Biomarkers

Membrane lipid compositionCholesterol levelsPhosphatidylserine exposureMembrane fluidity markers

Beyond the preview

Go deeper on Eukaryotic plasma membrane (PM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic plasma membrane (PM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call